ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Neurocrine Biosciences Inc

Neurocrine Biosciences Inc (NBIX)

152,8525
2,75
( 1,83% )
Aktualisiert: 21:08:38

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
152,8525
Gebot
152,76
Fragen
152,93
Volumen
393.195
150,18 Tagesbereich 153,88
110,95 52-Wochen-Bereich 157,9799
Marktkapitalisierung
Handelsende
150,10
Handelsbeginn
150,18
Letzte Trade
1
@
152.8476
Letzter Handelszeitpunkt
21:08:35
Finanzvolumen
US$ 59.934.930
VWAP
152,4306
Durchschnittliches Volumen (3 Mio.)
980.251
Ausgegebene Aktien
101.246.911
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
62,24
Gewinn pro Aktie (EPS)
2,47
Erlöse
1,89B
Nettogewinn
249,7M

Über Neurocrine Biosciences Inc

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is a... Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Neurocrine Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker NBIX. The last closing price for Neurocrine Biosciences was US$150,10. Over the last year, Neurocrine Biosciences shares have traded in a share price range of US$ 110,95 to US$ 157,9799.

Neurocrine Biosciences currently has 101.246.911 shares in issue. The market capitalisation of Neurocrine Biosciences is US$15,20 billion. Neurocrine Biosciences has a price to earnings ratio (PE ratio) of 62.24.

NBIX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
13.85252.5855704698149154.61148.02923824151.25509989CS
415.122510.9798155812137.73154.61136.84976488145.47409775CS
1225.902520.403702245126.95154.61115.27980251134.61995382CS
263.54252.37258053714149.31154.865110.95963027129.25080711CS
5211.67258.26781413798141.18157.9799110.95902147133.45341573CS
15673.572592.800832492479.28157.979975.25801480115.54006797CS
26051.742551.1744634556101.11157.979971.875820195108.77861271CS

NBIX - Frequently Asked Questions (FAQ)

What is the current Neurocrine Biosciences share price?
The current share price of Neurocrine Biosciences is US$ 152,8525
How many Neurocrine Biosciences shares are in issue?
Neurocrine Biosciences has 101.246.911 shares in issue
What is the market cap of Neurocrine Biosciences?
The market capitalisation of Neurocrine Biosciences is USD 15,2B
What is the 1 year trading range for Neurocrine Biosciences share price?
Neurocrine Biosciences has traded in the range of US$ 110,95 to US$ 157,9799 during the past year
What is the PE ratio of Neurocrine Biosciences?
The price to earnings ratio of Neurocrine Biosciences is 62,24
What is the cash to sales ratio of Neurocrine Biosciences?
The cash to sales ratio of Neurocrine Biosciences is 8,24
What is the reporting currency for Neurocrine Biosciences?
Neurocrine Biosciences reports financial results in USD
What is the latest annual turnover for Neurocrine Biosciences?
The latest annual turnover of Neurocrine Biosciences is USD 1,89B
What is the latest annual profit for Neurocrine Biosciences?
The latest annual profit of Neurocrine Biosciences is USD 249,7M
What is the registered address of Neurocrine Biosciences?
The registered address for Neurocrine Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Neurocrine Biosciences website address?
The website address for Neurocrine Biosciences is www.neurocrine.com
Which industry sector does Neurocrine Biosciences operate in?
Neurocrine Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CAPTCaptiVision Inc
US$ 1,37
(212,07%)
233,89M
QNTMQuantum Biopharma Ltd
US$ 5,77
(81,45%)
63,66M
LTRYLottery com Inc
US$ 0,5384
(72,56%)
119,64M
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 224,515
(44,55%)
1,62M
PLTUDirexion DAily PLTR Bull 2X Shares
US$ 47,62
(44,35%)
2,44M
OMGAOmega Therapeutics Inc
US$ 0,1595
(-66,71%)
8,58M
VIRXViracta Therapeutics Inc
US$ 0,043
(-44,73%)
5,51M
CYNCYNGN Inc
US$ 0,0731
(-37,47%)
91,94M
GCTKGlucoTrack Inc
US$ 0,7499
(-34,22%)
45,74M
CSAICloudastructure Inc
US$ 12,50
(-34,21%)
51,04k
CAPTCaptiVision Inc
US$ 1,37
(212,07%)
233,89M
PLTRPalantir Technologies Inc
US$ 102,7947
(22,75%)
202,1M
NVDANVIDIA Corporation
US$ 118,7096
(1,76%)
191,47M
RGTIRigetti Computing Inc
US$ 13,615
(1,08%)
147,3M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,1516
(-22,22%)
123,22M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock